Japan’s Kowa says ivermectin effective against Omicron in phase III trial – Reuters

Post author By EvidenceNotFear
Post date 31 January 2022

Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin has been found effective for treating the Omicron variant of COVID-19 in a Phase III trial.

http://archive.to d ay/2022.01.31-090451/https://www.reuters.com/article/health-coronavirus-japan-kowa/japans-kowa-says-ivermectin-effective-against-omicron-in-phase-iii-trial-idUSL1N2UB0AV

Tags COVID-19, Ivermectin, Japan, Kowa Co. Ltd., Omicron Variant, Phase III, Randomized Controlled Trials, Reuters, Trials

Info This site is a curated archive of articles with a link to the source. Keywords and topics covered in the publication can be found above. Click on the tag to view a listing of similar articles.
Links Are any links broken? The page may have been taken down. Visit archive.is or archive.org to view the archive snapshot.
Links Help fight censorship and preserve information on the internet. Archive this source and links on archive.is and archive.org. Save a local copy on your own hard drive.